Eli Lilly & Company (NYSE: LLY)
DRUGS - Drug Manufacturers - MajorSector: Health Care
Stock price data as of 09/22/2023
Closing price: 550.54
Support price level: | $484.81 |
Resistance price level: | N/A |
Relative strength index (14-day RSI) | 46.7 |
Beta | 0.19 |
- With a 85.7 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- The price of this low-beta stock is expected to increase by 0.19% for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
Low | High | Price as % of Range |
$307.50 | $599.30 | 87.3% |
200 day | 50 day | 20 day | 10 day |
$416.03 | $522.39 | $568.81 | $577.76 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
32.5% | 31.3% | 42.1% | 32.4% |
- 11.4% in the next week.
- 18.3% in the next month.
- .% in the next year.
Company news for Eli Lilly & Company
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks